Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity
作者： Essam Sheta , Ira L. Goldknopf , Maher Albitar , Hagop Kantarjian
DOI:
关键词:
摘要: The present invention provides methods and compositions for identifying cancer cells that are either sensitive or resistant to a particular anti-cancer therapy. Accordingly, the allows more accurate diagnosis, prognosis, monitoring of subject's condition. Furthermore, ability assess resistance sensitivity treatment regimen will permit informed decisions be made prior beginning also overcomes deficiencies in art concerning cancers by providing treating improving effectiveness other therapies.
lens.org 参考文章(5)
B. Alex Merrick, Rachel M. Patterson, Robert G. Hall, Chaoying He, James K. Selkirk, Preparative two dimensional gel electrophoresis system ,(1994)
Catherine Verfaillie, Method to identify genes associated with chronic myelogenous leukemia ,(2001)
Alex J Tipping, Michael W Deininger, John M Goldman, Junia V Melo, Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate Experimental Hematology. ,vol. 31, pp. 1073- 1080 ,(2003) , 10.1016/J.EXPHEM.2003.08.006
Giuliana Cassinelli, Cinzia Lanzi, Tiziana Pensa, Romolo A Gambetta, Gianluca Nasini, Giuditta Cuccuru, Marco Cassinis, Graziella Pratesi, Donatella Polizzi, Monica Tortoreto, Franco Zunino, Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin. Biochemical Pharmacology. ,vol. 59, pp. 1539- 1547 ,(2000) , 10.1016/S0006-2952(00)00278-1
Steven M. Kornblau, Guillermo Garcia-Manero, Michael Andreeff, Hagop M. Kantarjian, Charles Koller, Debra Resta, Moshe Talpaz, Mary Beth Rios, Jenny Shan, Terry L. Smith, Kimberly Hayes, Susan O'Brien, Jean Pierre J Issa, Michael Keating, Francis J. Giles, Jorge E. Cortes, Deborah A. Thomas, Stefan Faderl, Milosav Beran, Emil J. Freireich, Renaud Capdeville, Maher Albitar, Imatinib Mesylate for Philadelphia Chromosome-positive, Chronic-Phase Myeloid Leukemia after Failure of Interferon-α Follow-Up Results Clinical Cancer Research. ,vol. 8, pp. 2177- 2187 ,(2002)